Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria
Status:
Completed
Trial end date:
2000-05-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Evaluate the effectiveness of tin mesoporphyrin in reducing the number of heme
infusions needed to prevent acute attacks of porphyria.
II. Evaluate the safety and tolerability of tin mesoporphyrin in these patients.